Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk factors associated with urinary tract infection within 4 days of male rectal cancer surgery in the era of enhanced recovery after surgery (ERAS) programs.

Acta chirurgica Belgica·2026
Same author

Chemotherapy followed by pelvic reirradiation versus chemotherapy alone as preoperative treatment for locally recurrent rectal cancer (GRECCAR 15): superiority open-label phase III randomized clinical trial.

The British journal of surgery·2026
Same author

Organ Preservation in Rectal Cancer Management: A Prospective GRECCAR Snapshot Study.

Diseases of the colon and rectum·2026
Same author

Outcomes after ventral mesh removal: a multicentric cohort study.

Hernia : the journal of hernias and abdominal wall surgery·2026
Same author

Outcomes of inguinal hernia repair after implantation of preperitoneal reservoir for artificial urinary sphincter or penile implant.

BMC surgery·2026
Same author

Postoperative Hepatic Arterial Infusion With Oxaliplatin After Surgery of Four or More Colorectal Liver Metastases: A Randomized Phase II Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Related Experiment Video

Updated: Jun 24, 2026

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

[Malignant primary peritoneal tumors].

Eddy Cotte1, Guillaume Passot, Sylvie Isaac

  • 1Service de chirurgie générale, thoracique et endocrinienne, Centre hospitalier Lyon-Sud, F-69495 Pierre Bénite Cedex, France.

Presse Medicale (Paris, France : 1983)
|April 10, 2009
PubMed
Summary
This summary is machine-generated.

Malignant primary peritoneal tumors are rare but crucial to consider in unexplained peritoneal carcinomatosis. Diagnosis and management require specialized care, often involving cytoreductive surgery and chemotherapy.

More Related Videos

An Ex Vivo Model of Ovarian Cancer Peritoneal Metastasis Using Human Omentum
05:42

An Ex Vivo Model of Ovarian Cancer Peritoneal Metastasis Using Human Omentum

Published on: January 26, 2024

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis
10:58

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Published on: July 18, 2016

Related Experiment Videos

Last Updated: Jun 24, 2026

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

An Ex Vivo Model of Ovarian Cancer Peritoneal Metastasis Using Human Omentum
05:42

An Ex Vivo Model of Ovarian Cancer Peritoneal Metastasis Using Human Omentum

Published on: January 26, 2024

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis
10:58

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Published on: July 18, 2016

Area of Science:

  • Oncology
  • Pathology

Context:

  • Malignant primary peritoneal tumors are rare entities.
  • Peritoneal carcinomatosis without a known primary tumor necessitates considering these rare malignancies.
  • Key etiologies include peritoneal mesothelioma, pseudomyxoma peritonei, and primary peritoneal serous carcinoma.

Purpose:

  • To highlight the importance of considering rare malignant primary peritoneal tumors.
  • To outline diagnostic approaches, emphasizing laparoscopic biopsy with precautions against tumor spread.
  • To describe the standard treatment, including cytoreductive surgery and perioperative intraperitoneal chemotherapy.

Summary:

  • Diagnosis often requires laparoscopic biopsy, with careful attention to port site selection to prevent tumor dissemination.
  • The gold standard treatment involves optimal cytoreductive surgery combined with perioperative intraperitoneal chemotherapy.
  • Management should occur in specialized centers and national networks (RENAPE) for complex care and research facilitation.

Impact:

  • Improved diagnostic awareness for rare peritoneal malignancies.
  • Standardization of treatment protocols through specialized centers and networks.
  • Facilitation of clinical and fundamental research in rare peritoneal diseases.